perindoprilat has been researched along with hydralazine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Benetos, A; Legrand, M; London, GM; Safar, ME; Tsoucaris, D | 1 |
| Bemelmans, M; Boudier, HS; Crijns, F; Huijberts, M; Kruseman, AN; Smits, J; Van Essen, H; Wolffenbuttel, B | 1 |
3 other study(ies) available for perindoprilat and hydralazine
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Proximal and distal pulse pressure after acute antihypertensive vasodilating drugs in Wistar-Kyoto and spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Heart Rate; Hydralazine; Hypertension; Indoles; Male; Nicardipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasodilator Agents | 1995 |
Inhibition of angiotensin-converting enzyme reduces urinary albumin excretion but not regional albumin clearance in experimental diabetes.
Topics: Albumins; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Capillary Permeability; Diabetes Mellitus, Experimental; Hydralazine; Indoles; Male; Random Allocation; Rats; Rats, Wistar | 1993 |